CymaBay Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on CymaBay Therapeutics Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how CymaBay Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with CymaBay Therapeutics Inc.

Back to companies

CymaBay Therapeutics Inc: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

CymaBay Therapeutics Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for CymaBay Therapeutics Inc’s relevant decision makers and contact details.

A sample of CymaBay Therapeutics Lead Sheet data

Lead Date Lead Type Lead Description Company Name Drug Name Therapy Area
Showing 3 of 30+ results.
30 Jan 2023 GDCTWXYZ Lorem Lorem Lorem Cardiovascular
24 Jan 2023 Capital Raisings CymaBay Therapeutics Prices Public Offering of Shares for USD85 Million CymaBay Therapeutics Inc arhalofenate; CB-001; MBX-2044; MBX-2982; seladelpar lysine; Small Molecule 1 for Type 2 Diabetes; Small Molecule 2 for Type 2 Diabetes; Small Molecule for Type 2 Diabetes and Obesity; Small Molecules 3 For Type 2 Diabetes; Small Molecules to Agonize GPCRs for Diabetes Gastrointestinal; Immunology; Metabolic Disorders; Musculoskeletal Disorders
04 Nov 2022 Trial Results Announced Phase III Trial Result (Other Results) announced on 04-Nov-2022 CymaBay Therapeutics Inc seladelpar lysine Dermatology; Gastrointestinal
02 Nov 2022 New Appointment Charles McWherter appointed as President, Research and Development CymaBay Therapeutics Inc - -
Lead Sheet

Feature

Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.

  • Lead: Any current or future events that signal a company may need services from another company in the near future.

Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.

Benefit

Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.

Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.

Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.

Value

Lead Sheet is a business development tool to help optimize sales efficiency

  • What prospective accounts to target
  • When and why to target them through actionable leads/opportunities
  • Who to reach out to

Premium databases is part of our industry range of products

Gain a 360-degree view of CymaBay Therapeutics Inc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer